Atlas Venture went through a corporate divorce last fall, as its tech partners and biotech partners went their separate ways. Now the biotech team has moved on, and re-loaded with twice the money they’ve had in the past.The Cambridge, Mass.-based firm, founded back in 1980, is announcing today it has closed on a new $280 million fund, its tenth, to […]
On Wednesday, Athersys, Inc. (NASDAQ:ATHX)’s shares declined -11.74% to $2.63.Athersys, Inc. (ATHX) will release its first quarter 2015 financial results at about 4:00 PM EDT on Monday, May 11, 2015, and host a conference call shortly thereafter at 4:30 PM EDT to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief […]
Source: Ligand PharmaceuticalsHow hot is biotech these days? The top two exchange trade funds focusing on biotech stocks both more than tripled the performance of the S&P 500 index over the past 12 months. That’s pretty hot.You might be asking, however, if it’s too late to still make solid returns in this sizzling sector. Not at all. There are plenty […]
Biotech bubble may just be an optical illusion
By iCELL News on March 27, 2015 · Sector
SAN FRANCISCO (MarketWatch)—The stellar performance of biotechnology stocks in the past few years has predictably sparked fears of an impending crash. But for all the talk of a bubble, biotechs are far from being overbought, according to analysts at Credit Suisse.“There are optics suggesting that […]
The multiyear run in major biotech stocks has not let up in 2015. Most of the large and mid-cap stocks in the industry are higher, but the smaller and lesser known names have also tracked them higher. In fact, several biotechs are up 200% or more so far in 2015.24/7 Wall St. ran a screen for the top five biotech […]
LONDON, March 19, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Cytori Therapeutics Inc. (NASDAQ: CYTX), Oncolytics Biotech Inc. (NASDAQ: ONCY), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Aeterna Zentaris Inc. (NASDAQ: AEZS), and Immunomedics Inc. (NASDAQ: IMMU). Free research report on Cytori Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Cytori%20Therapeutics&d=19-Mar-2015&s=CYTX. […]
LONDON, March 18, 2015 /PRNewswire/ —Editor Note: For more information about this release, please scroll to bottom.Investor-Edge has initiated coverage on the following equities: Orexigen Therapeutics Inc. (NASDAQ: OREX), Celgene Corporation (NASDAQ: CELG), PDL BioPharma Inc. (NASDAQ: PDLI), Amarin Corporation PLC (NASDAQ: AMRN), and Synergy Pharmaceuticals Inc. (NASDAQ: SGYP). Free research report on Orexigen Therapeutics can be accessed at http://get.Investor-Edge.com/pdf/?c=Orexigen%20Therapeutics&d=18-Mar-2015&s=OREX. […]
In a recent report, analysts at Maxim Group discussed the biotechnology sector and gave their outlook for five names in the space. Here’s a rundown of what they had to say.Athersys, Inc. (NASDAQ: ATHX)Analysts believe that Athersys may have found a “sweet spot” for stroke treatment timing, as data from a phase II trial of MultiStem treatment one to two […]
Related ACHNAfter-Hours Movers Led By Bob Evans, Bazaarvoice And Smith & Wesson On TuesdayTop 5 Biotech Stocks That The Smart Money Doesn’t LikeAchillion Pharma updates guidance after Q4 results(Seeking Alpha)Barclays announced expanded coverage on seven biotech stocks Wednesday. Below are the new ratings and price targets along with comments from analyst Geoff Meacham.Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) was rated at […]
Fits and starts in developing a revolutionary new inhaled insulin have meant that Al Mann’s MannKind has had more than its fair share of pops and drops over the past few years. MannKind won FDA approval for Afrezza last summer and announced its commercial launch earlier this month . The news has investors wondering if now is a good time […]
